Panacea Biotec Limited Sustainability Profile
Panacea Biotec Limited, a prominent player in the biopharmaceutical industry, is headquartered in India and operates extensively across various regions, including Europe, Africa, and Asia. Founded in 1984, the company has achieved significant milestones, establishing itself as a leader in the development and manufacturing of vaccines, biopharmaceuticals, and complex generics. Panacea Biotec is renowned for its innovative core products, including a range of vaccines that address critical health challenges, such as hepatitis and polio. The company’s commitment to quality and research-driven solutions sets it apart in a competitive market. With a strong focus on sustainability and social responsibility, Panacea Biotec has garnered recognition for its contributions to public health, solidifying its position as a trusted name in the biopharmaceutical sector.
DitchCarbon Score
How does Panacea Biotec Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Panacea Biotec Limited's score of 16 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Panacea Biotec Limited's reported carbon emissions
Panacea Biotec Limited, headquartered in India, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Consequently, the company has not established any formal reduction targets or commitments under frameworks such as the Science Based Targets initiative (SBTi). As of now, Panacea Biotec Limited has not disclosed any climate pledges or initiatives aimed at reducing its carbon footprint. The absence of emissions data and reduction commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the context of the pharmaceutical industry, where sustainability and climate action are increasingly important, Panacea Biotec Limited may benefit from establishing clear targets and reporting mechanisms to align with industry standards and stakeholder expectations.
How Carbon Intensive is Panacea Biotec Limited's Industry?
How Carbon Intensive is Panacea Biotec Limited's Location?
Panacea Biotec Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Panacea Biotec Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
